The Ebola outbreak, declared on 15 May, has killed more than 2,000 people and generated thousands of additional reported cases. The WHO chief says its trajectory could make it the deadliest Ebola outbreak on record.
9:31 PMBBC28 stories from 11 sources
Ebola nears record toll as health policy clashes intensify
Day’s Recap
Supporting Articles
The Ebola outbreak in the Democratic Republic of the Congo is on pace to surpass the West African outbreak of 2014 to 2016 as the deadliest on record. The WHO says that outcome will occur if infections continue at their current rate.
2:23 PMAl Jazeera
The World Health Organization criticized the White House order seeking to overhaul the vaccine schedule. Health leaders warned that the changes could expose children to more injections and greater disease risk.
2:03 PMStat News
The WHO chief criticized claims by the US health secretary that the MMR vaccine causes autism, noting that no medical evidence supports that link. The dispute places a senior US health official at odds with the established scientific consensus on vaccine safety.
11:30 AMAl Jazeera
Cyclospora cases continue to rise despite HHS declaring the outbreak contained and saying salad is safe to eat. CDC data through August 11 showed nearly 14,000 confirmed cases, a 33% increase, and another 10,000 cases under investigation, while inconsistent reporting rules have widened the gap between federal and state counts.
5:30 PMBloomberg Markets
The Trump administration's new addiction toolkit emphasizes treatment, faith, and abstinence while acknowledging the use of addiction medications. It moves away from other harm reduction strategies.
3:43 PMStat News
A new study finds that patients across the cancers examined are waiting longer to start treatment than they did a decade ago.
11:00 AMStat News
Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of retatrutide, its experimental obesity drug.
9:22 AMStat News9:31 PMBBC
Ebola outbreak on track to be deadliest ever, WHO chief says
Summary
The Ebola outbreak, declared on 15 May, has killed more than 2,000 people and generated thousands of additional reported cases. The WHO chief says its trajectory could make it the deadliest Ebola outbreak on record.
Crossing 2,000 deaths shows the outbreak is expanding beyond the reach of current containment efforts.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The outbreak's scale raises the risk of a wider public-health emergency and increases pressure for an urgent international response.
2:23 PMAl Jazeera
DR Congo Ebola outbreak set to become deadliest on record, WHO warns
Summary
The Ebola outbreak in the Democratic Republic of the Congo is on pace to surpass the West African outbreak of 2014 to 2016 as the deadliest on record. The WHO says that outcome will occur if infections continue at their current rate.
The outbreak has reached a trajectory that could exceed the previous global Ebola death toll
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A record Ebola outbreak would signal that containment is failing and increase the danger of regional spread.
2:03 PMStat News
WHO says Trump’s latest vaccine policy order is misguided
Summary
The World Health Organization criticized the White House order seeking to overhaul the vaccine schedule. Health leaders warned that the changes could expose children to more injections and greater disease risk.
The order has triggered a direct clash between the administration's vaccine policy and international public
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A federal vaccine schedule change could affect childhood disease risk, medical guidance, and public trust.
11:30 AMAl Jazeera
WHO chief says Trump vaccine push goes against ‘decades of evidence’
Summary
The WHO chief criticized claims by the US health secretary that the MMR vaccine causes autism, noting that no medical evidence supports that link. The dispute places a senior US health official at odds with the established scientific consensus on vaccine safety.
The decisive change is the elevation of a disproven vaccine claim within US health leadership,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Government endorsement of unsupported vaccine claims can translate directly into lower immunization rates and preventable disease.
5:30 PMBloomberg Markets
Former CDC Official on the Cyclospora Outbreak
Summary
Cyclospora cases continue to rise despite HHS declaring the outbreak contained and saying salad is safe to eat. CDC data through August 11 showed nearly 14,000 confirmed cases, a 33% increase, and another 10,000 cases under investigation, while inconsistent reporting rules have widened the gap between federal and state counts.
The decisive shift is the divergence between the federal containment message and the CDC's rising
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Conflicting case counts can delay targeted action and undermine public trust in food safety guidance.
3:43 PMStat News
Trump administration’s new ‘treatment first’ addiction toolkit emphasizes faith, abstinence
Summary
The Trump administration's new addiction toolkit emphasizes treatment, faith, and abstinence while acknowledging the use of addiction medications. It moves away from other harm reduction strategies.
The toolkit shifts federal addiction policy toward abstinence and faith-based treatment rather than a broader
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Federal treatment priorities shape what care patients can access and which approaches receive public support and resources.
11:00 AMStat News
STAT+: Cancer patients face longer wait times to begin treatment, according to new study
Summary
A new study finds that patients across the cancers examined are waiting longer to start treatment than they did a decade ago.
The broad rise in treatment delays points to system-level capacity problems rather than an issue
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Treatment delays can turn cancer care into a race against both disease progression and an overstretched health system.
9:22 AMStat News
STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more
Summary
Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of retatrutide, its experimental obesity drug.
Lilly is escalating enforcement against suppliers before retatrutide has reached the market, aiming to protect
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The legal fight shows how rapidly demand for experimental obesity drugs is creating a parallel market before regulators approve the treatment.
3 stories · 3 sources
Other Developments
A curated list of other prominent stories from this day.
The Democratic Republic of the Congo and the WHO are working to accelerate a multi-arm Phase 3 clinical trial of Ebola vaccines. The trial would compare vaccine strategies in a setting where the disease remains an active public health threat.
4:46 PMStat News
A new survey found that young adults’ use of vaping products and cannabis reached record levels in 2025. The results point to continued growth in use among a population already facing risks from nicotine dependence and cannabis exposure.
4:30 PMStat News
Healthcare providers secured a legal victory under the No Surprises Act that could increase payments for some out-of-network care. The change may also raise costs for insurers and patients in affected cases.
4:29 PMStat News
The Coalition for Health AI has created a Health AI Cybersecurity Work Group to develop practical, peer-developed guidance on cyber risks and readiness for frontier AI models in healthcare. The group aims to give healthcare organizations a common framework for managing attacks against increasingly capable AI systems.
3:18 PMPYMNTS
Apollo Hospitals reported a 38.4% year-on-year increase in Q1FY27 net profit to ₹610 crore, while revenue rose 20.6% to ₹7,044 crore. EBITDA grew 28.2%, supported by higher patient volumes, complex procedures, capacity expansion and international patients.
11:43 AMEconomic Times
The opinion argues that the Lindsay Clancy case exposes major weaknesses in the understanding, detection, and treatment of postpartum psychiatric illness.
10:51 AMStat News
Researchers suggest that GLP-1 drugs may reduce cravings for alcohol and other addictive substances by acting on the lateral septum, a brain region involved in linking memories and surroundings to reward. The region’s concentration of GLP-1 receptors makes it a possible target for addiction treatments.
10:36 AMScienceDaily
Actor Lucy Davis has disclosed that she is living with incurable Stage 4 breast cancer, prompting public support from former collaborators and fellow actors.
9:32 AMVariety
Researchers identified a brain network and electrical rhythm associated with the benefits of deep brain stimulation in Parkinson's disease. The finding could help clinicians tailor stimulation settings more precisely for individual patients.
9:20 AMScienceDaily
The report examines the difficult process of building and selling AI tools to medical clinics, alongside other developments in health technology.
8:09 AMStat News
Definium Therapeutics said its LSD-based therapy significantly reduced symptoms in patients with generalized anxiety disorder in the first of two large clinical trials.
8:01 AMStat News
Keratin extracted from sheep’s wool helped damaged bones regenerate in animals, producing more organized tissue than conventional collagen scaffolds. The work suggests that wool, an abundant agricultural byproduct, could provide a useful material for regenerative medicine.
7:17 AMScienceDaily
German autoimmune researcher Georg Schett is co-founding a biotechnology company focused on antibody therapies. The company is beginning to outline how it plans to translate his research into treatments for autoimmune disease.
6:30 AMStat News
The article argues that climate change is already worsening illness, with people who have chronic conditions facing heightened health risks. It frames climate-driven heat and other environmental pressures as an immediate medical problem rather than a distant threat.
4:30 AMStat News
Experts say Neurocrine Biosciences' newly approved drug for Prader-Willi syndrome may be connected to a series of patient deaths. The condition causes an often relentless drive to eat, and the drug is intended to help manage it.
4:30 AMStat News
Commure is pursuing an ambitious plan to use artificial intelligence to automate health care's administrative work. An inside account examines the operational and organizational problems that have complicated the startup's effort.
4:30 AMStat News
Ongoing bombardment in Gaza has disrupted the routines that autistic children often depend on, producing sensory distress and behavioral setbacks. Families are coping with those effects amid destruction, displacement, and loss.
3:27 AMAl JazeeraA potential $400 billion agreement involving AstraZeneca unraveled after a broad investor backlash. The opposition became a central obstacle to completing the deal.
12:00 AMFinancial Times4:46 PMStat News
Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says
Summary
The Democratic Republic of the Congo and the WHO are working to accelerate a multi-arm Phase 3 clinical trial of Ebola vaccines. The trial would compare vaccine strategies in a setting where the disease remains an active public health threat.
The immediate change is movement from outbreak response toward comparative evidence on which Ebola vaccines
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A rigorous trial could determine how governments choose and deploy Ebola vaccines during future outbreaks.
4:30 PMStat News
Vaping and cannabis hit record highs among young adults in 2025: Survey
Summary
A new survey found that young adults’ use of vaping products and cannabis reached record levels in 2025. The results point to continued growth in use among a population already facing risks from nicotine dependence and cannabis exposure.
The increase suggests that prevention and regulation have not contained use among young adults, even
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Record use among young adults could produce a larger future burden of addiction and preventable health problems.
4:29 PMStat News
STAT+: Providers notch No Surprises Act legal win that could boost their pay
Summary
Healthcare providers secured a legal victory under the No Surprises Act that could increase payments for some out-of-network care. The change may also raise costs for insurers and patients in affected cases.
The ruling shifts leverage toward providers in disputes over payment amounts, potentially increasing the rates
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A provider-favorable interpretation of the law could raise out-of-network payments and feed into broader healthcare costs.
3:18 PMPYMNTS
Coalition for Health AI Mounts Effort Against Cyberattacks
Summary
The Coalition for Health AI has created a Health AI Cybersecurity Work Group to develop practical, peer-developed guidance on cyber risks and readiness for frontier AI models in healthcare. The group aims to give healthcare organizations a common framework for managing attacks against increasingly capable AI systems.
Healthcare AI governance is expanding from responsible use and model quality to operational cybersecurity. The
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Healthcare needs security practices tailored to AI systems before frontier models become embedded in clinical operations.
11:43 AMEconomic Times
Apollo Hospitals Q1 Results: Net profit jumps 38% YoY to Rs 610 crore; revenue rises 21%
Summary
Apollo Hospitals reported a 38.4% year-on-year increase in Q1FY27 net profit to ₹610 crore, while revenue rose 20.6% to ₹7,044 crore. EBITDA grew 28.2%, supported by higher patient volumes, complex procedures, capacity expansion and international patients.
Apollo’s profit growth outpaced revenue growth, indicating stronger operating leverage alongside expanding demand for higher-acuity
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The results show a major Indian hospital operator converting rising healthcare demand into faster earnings growth.
10:51 AMStat News
Opinion: The Lindsay Clancy case shows the limits of postpartum psychiatry
Summary
The opinion argues that the Lindsay Clancy case exposes major weaknesses in the understanding, detection, and treatment of postpartum psychiatric illness.
The case raises a systems question: whether existing postpartum mental-health care can identify severe illness
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Postpartum psychiatric illness remains a preventable source of harm when fragmented care fails to match the severity of patients' needs.
10:36 AMScienceDaily
Ozempic may have revealed the brain’s hidden “craving center”
Summary
Researchers suggest that GLP-1 drugs may reduce cravings for alcohol and other addictive substances by acting on the lateral septum, a brain region involved in linking memories and surroundings to reward. The region’s concentration of GLP-1 receptors makes it a possible target for addiction treatments.
The research broadens GLP-1 drugs from appetite control into a possible treatment pathway for compulsive
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The same drug class reshaping obesity care could eventually influence how clinicians treat addiction.
9:32 AMVariety
Lucy Davis Supported by Fellow ‘The Office’ Alum Jenna Fischer, ‘Sabrina’ Star Kiernan Shipka and More After ‘Incurable’ Cancer Diagnosis
Summary
Actor Lucy Davis has disclosed that she is living with incurable Stage 4 breast cancer, prompting public support from former collaborators and fellow actors.
The disclosure brings attention to the continuing treatment and uncertainty faced by people with metastatic
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The case underscores the gap between improved cancer care and the reality that metastatic disease often remains incurable.
9:20 AMScienceDaily
Scientists discover a hidden brain rhythm that could improve Parkinson’s treatment
Summary
Researchers identified a brain network and electrical rhythm associated with the benefits of deep brain stimulation in Parkinson's disease. The finding could help clinicians tailor stimulation settings more precisely for individual patients.
The important change is a shift from treating stimulation as a largely fixed intervention to
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A biological marker for treatment response could make deep brain stimulation more personalized and effective.
8:09 AMStat News
STAT+: The secret AI-startup project I’ve been working on the last six months
Summary
The report examines the difficult process of building and selling AI tools to medical clinics, alongside other developments in health technology.
Health AI companies are moving tools into clinical settings faster than many can validate their
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The central constraint on clinical AI is shifting from invention to proving that hastily deployed products are safe and useful in real care.
8:01 AMStat News
STAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial
Summary
Definium Therapeutics said its LSD-based therapy significantly reduced symptoms in patients with generalized anxiety disorder in the first of two large clinical trials.
A positive first late-stage trial strengthens the case for psychedelic-based treatment of anxiety, but it
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The result moves psychedelic medicine closer to a regulatory test while leaving efficacy, safety, and scalability questions unresolved.
7:17 AMScienceDaily
Scientists turn sheep’s wool into a material that helps regrow bone
Summary
Keratin extracted from sheep’s wool helped damaged bones regenerate in animals, producing more organized tissue than conventional collagen scaffolds. The work suggests that wool, an abundant agricultural byproduct, could provide a useful material for regenerative medicine.
The important advance is material performance, not just waste recycling: the keratin scaffold supported tissue
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A low-cost biological waste product could become a scalable source of bone-repair materials if the results translate clinically.
6:30 AMStat News
STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies
Summary
German autoimmune researcher Georg Schett is co-founding a biotechnology company focused on antibody therapies. The company is beginning to outline how it plans to translate his research into treatments for autoimmune disease.
The company is placing a prominent academic track record at the center of a new
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The venture reflects continued biotech investment in targeted antibody treatments for autoimmune disease.
4:30 AMStat News
Opinion: Climate change is making people with chronic illness even sicker
Summary
The article argues that climate change is already worsening illness, with people who have chronic conditions facing heightened health risks. It frames climate-driven heat and other environmental pressures as an immediate medical problem rather than a distant threat.
The burden falls hardest on people whose health leaves them less able to tolerate heat,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Climate change is expanding the risks and costs of chronic illness while testing the resilience of everyday medical care.
4:30 AMStat News
STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say
Summary
Experts say Neurocrine Biosciences' newly approved drug for Prader-Willi syndrome may be connected to a series of patient deaths. The condition causes an often relentless drive to eat, and the drug is intended to help manage it.
The central issue is a possible safety signal emerging after approval, not an established causal
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A possible link to deaths could reshape prescribing and trigger regulatory scrutiny for a drug aimed at a severe, poorly treated disorder.
4:30 AMStat News
STAT+: Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health care
Summary
Commure is pursuing an ambitious plan to use artificial intelligence to automate health care's administrative work. An inside account examines the operational and organizational problems that have complicated the startup's effort.
The challenge is not just building AI tools but integrating them into fragmented, high-stakes workflows
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The push to automate health care will be judged less by technical demonstrations than by whether systems can deliver reliable savings without creating new operational risks.
3:27 AMAl Jazeera
Autism and war: Gaza families grapple with destruction and loss
Summary
Ongoing bombardment in Gaza has disrupted the routines that autistic children often depend on, producing sensory distress and behavioral setbacks. Families are coping with those effects amid destruction, displacement, and loss.
War removes the structure, safety, and specialized support that many autistic children need to regulate
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The story shows how conflict magnifies disability-related vulnerability when health services, routines, and safe environments collapse.
12:00 AMFinancial Times
How AstraZeneca’s $400bn deal unravelled
Summary
A potential $400 billion agreement involving AstraZeneca unraveled after a broad investor backlash. The opposition became a central obstacle to completing the deal.
Investor resistance, rather than the strategic rationale alone, determined the deal’s outcome. The collapse limits
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The episode shows that even the largest healthcare deals can fail when investors reject the valuation or strategic case.
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!